...
search icon
cldi-img

Calidi Biotherapeutics Inc. Share Price

CLDI
ASQ
$0.7317
-$0.02
(-2.67%)
1D
Industry: Biotechnology Sector: Health Care

Calidi Biotherapeutics Inc. Analyst Forecast

Calidi Biotherapeutics Inc. Share Price Chart

Calidi Biotherapeutics Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.38M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
2.0836
Volume info-icon
This is the total number of shares traded during the most recent trading day.
52.66K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.09
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.72 L
$15.6 H
$0.7317

About Calidi Biotherapeutics Inc., Common Stock

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Calidi Biotherapeutics Inc. Stock Returns

Time FrameCLDISectorS&P500
1-Week Return0.03%1.07%0.74%
1-Month Return-24.73%1.46%1.28%
3-Month Return-47.21%3.51%3.6%
6-Month Return-74.66%15.29%7.31%
1-Year Return-94.76%7.7%11.97%
3-Year Return-99.94%21.02%72.07%
5-Year Return-99.94%37.81%76.01%

Calidi Biotherapeutics Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-449.00K45.00K--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":10.02,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue-94.00K274.00K1.26M1.53M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":6.12,"profit":true},{"date":"2022-12-31","value":17.85,"profit":true},{"date":"2023-12-31","value":81.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit-355.00K(229.00K)(1.26M)(1.53M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-64.51,"profit":false},{"date":"2023-12-31","value":-353.8,"profit":false},{"date":"2024-12-31","value":-432.39,"profit":false}]
Gross Margin-79.06%(508.89%)--[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-643.64,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses6.77M10.84M22.90M27.74M21.78M[{"date":"2020-12-31","value":24.42,"profit":true},{"date":"2021-12-31","value":39.07,"profit":true},{"date":"2022-12-31","value":82.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":78.51,"profit":true}]
Operating Income(6.77M)(10.48M)(23.13M)(28.99M)(21.78M)[{"date":"2020-12-31","value":-677300000,"profit":false},{"date":"2021-12-31","value":-1048200000,"profit":false},{"date":"2022-12-31","value":-2312800000,"profit":false},{"date":"2023-12-31","value":-2899200000,"profit":false},{"date":"2024-12-31","value":-2177600000,"profit":false}]
Total Non-Operating Income/Expense(1.32M)13.27M(2.41M)(3.96M)(1.35M)[{"date":"2020-12-31","value":-9.97,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-18.17,"profit":false},{"date":"2023-12-31","value":-29.83,"profit":false},{"date":"2024-12-31","value":-10.19,"profit":false}]
Pre-Tax Income(7.93M)3.40M(25.42M)(29.20M)(22.20M)[{"date":"2020-12-31","value":-233.48,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-748.02,"profit":false},{"date":"2023-12-31","value":-859.39,"profit":false},{"date":"2024-12-31","value":-653.23,"profit":false}]
Income Taxes4.00K11.00K11.00K16.00K14.00K[{"date":"2020-12-31","value":25,"profit":true},{"date":"2021-12-31","value":68.75,"profit":true},{"date":"2022-12-31","value":68.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":87.5,"profit":true}]
Income After Taxes(7.94M)3.39M(25.43M)(29.22M)(22.21M)[{"date":"2020-12-31","value":-234.35,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-750.78,"profit":false},{"date":"2023-12-31","value":-862.66,"profit":false},{"date":"2024-12-31","value":-655.76,"profit":false}]
Income From Continuous Operations(7.94M)(10.93M)(21.16M)(29.22M)(22.21M)[{"date":"2020-12-31","value":-793700000,"profit":false},{"date":"2021-12-31","value":-1093300000,"profit":false},{"date":"2022-12-31","value":-2116000000,"profit":false},{"date":"2023-12-31","value":-2921600000,"profit":false},{"date":"2024-12-31","value":-2220900000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(7.94M)(10.93M)(25.43M)(29.22M)(22.14M)[{"date":"2020-12-31","value":-793700000,"profit":false},{"date":"2021-12-31","value":-1093300000,"profit":false},{"date":"2022-12-31","value":-2542700000,"profit":false},{"date":"2023-12-31","value":-2921600000,"profit":false},{"date":"2024-12-31","value":-2214300000,"profit":false}]
EPS (Diluted)-0.12(0.05)(28.08)(2.52)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-41.67,"profit":false},{"date":"2023-12-31","value":-23396.83,"profit":false},{"date":"2024-12-31","value":-2100,"profit":false}]

Calidi Biotherapeutics Inc. Ratios

Calidi Biotherapeutics Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

CLDI
Cash Ratio 2.00
Current Ratio 2.12

Calidi Biotherapeutics Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CLDI
ROA (LTM) -119.65%
ROE (LTM) 0.00%

Calidi Biotherapeutics Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CLDI
Debt Ratio Lower is generally better. Negative is bad. 0.49
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.49

Calidi Biotherapeutics Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CLDI
Trailing PE 2.08
Forward PE NM
P/S (TTM) 50.83
P/B 0.81
Price/FCF NM
EV/R 49.42
EV/Ebitda NM

FAQs

What is Calidi Biotherapeutics Inc. share price today?

Calidi Biotherapeutics Inc. (CLDI) share price today is $0.7317

Can Indians buy Calidi Biotherapeutics Inc. shares?

Yes, Indians can buy shares of Calidi Biotherapeutics Inc. (CLDI) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLDI stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Calidi Biotherapeutics Inc. be purchased?

Yes, you can purchase fractional shares of Calidi Biotherapeutics Inc. (CLDI) via the Vested app. You can start investing in Calidi Biotherapeutics Inc. (CLDI) with a minimum investment of $1.

How to invest in Calidi Biotherapeutics Inc. shares from India?

You can invest in shares of Calidi Biotherapeutics Inc. (CLDI) via Vested in three simple steps:

  • Click on Sign Up or Invest in CLDI stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Calidi Biotherapeutics Inc. shares
What is Calidi Biotherapeutics Inc. 52-week high and low stock price?

The 52-week high price of Calidi Biotherapeutics Inc. (CLDI) is $15.6. The 52-week low price of Calidi Biotherapeutics Inc. (CLDI) is $0.72.

What is Calidi Biotherapeutics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Calidi Biotherapeutics Inc. (CLDI) is 2.0836

What is Calidi Biotherapeutics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Calidi Biotherapeutics Inc. (CLDI) is 0.81

What is Calidi Biotherapeutics Inc. dividend yield?

The dividend yield of Calidi Biotherapeutics Inc. (CLDI) is 0.00%

What is the Market Cap of Calidi Biotherapeutics Inc.?

The market capitalization of Calidi Biotherapeutics Inc. (CLDI) is $5.38M

What is Calidi Biotherapeutics Inc.'s stock symbol?

The stock symbol (or ticker) of Calidi Biotherapeutics Inc. is CLDI

How Can Investors Use Calidi Biotherapeutics Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Calidi Biotherapeutics Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Calidi Biotherapeutics Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Calidi Biotherapeutics Inc. shares for Indian investors?

When investing in Calidi Biotherapeutics Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Calidi Biotherapeutics Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Calidi Biotherapeutics Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Calidi Biotherapeutics Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Calidi Biotherapeutics Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top